Project Grant F31DC022526

Award Date 1/31/25
Completion Date 8/31/27
Dollars Obligated $94K
Federal Grant Program
93.173
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94158, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $619,474 in funding to The Regents of the University of California, San Francisco (UCSF) to study the molecular mechanisms by which the cohesin protein complex regulates gene expression and neural wiring during brain development. The key objectives of this 5-year research project...
This federal Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $216,000.00 to the University of California, San Diego (UCSD) to elucidate the function of CTCF, a key protein involved in chromatin organization, in neural differentiation and neurodevelopment. The research will employ both 2D and 3D human cell models to examine the role...
This three-year, $4.45 million project grant from the National Institutes of Health's Trans-NIH Research Support program will fund research into unraveling the developmental relationship between gene expression and long-range cortical projections in neurons. The Allen Institute will receive the funding to improve the resolution and scale of in situ sequencing-based neuroanatomical approaches. This will generate an unprecedented view of how gene expression correlates with and influences the...
This $718,662 Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), supports research to characterize the genetic regulation of alternative polyadenylation (APA) in the developing human brain and its contribution to neuropsychiatric disorders like autism spectrum disorder (ASD) and schizophrenia (SCZ). The project aims to generate a comprehensive atlas of APA regulation across neurodevelopment, leveraging data from...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $1,111,187 to Georgetown University to investigate the role of the chromatin remodeling protein CHD1 in regulating synaptic homeostatic plasticity and its relevance to autism spectrum disorder (ASD) and related neurodevelopmental conditions. The research aims to delineate the signaling pathways controlled by CHD1 that stabilize synaptic...
This $1.8 million project grant from the National Institutes of Health's National Institute of Mental Health will fund the development of high-throughput methods for measuring synaptic connectivity at single-cell resolution in the cerebral cortex. Over a three-year period from September 2022 through August 2025, The Broad Institute, Inc. will pursue viral, functional, and molecular approaches to map local cortical circuitry. These include optimizing rabies-based trans-synaptic tracing for...
The National Science Foundation (NSF) awarded a 5-year, $399,835 CAREER grant under the Biological Sciences program (CFDA 47.074) to the Massachusetts Institute of Technology (MIT) to investigate how transcription and loop extrusion regulate 3D genome structure. The project aims to improve the understanding of how a single genome gives rise to diverse cell types by studying the dynamics of CTCF-mediated DNA loops and topologically associating domains (TADs). The work will integrate advanced...
This $21.4 million cooperative agreement from the National Institute of Mental Health will fund research to identify gene regulatory elements that can target and manipulate specific neuronal cell types and brain circuits across species, including in human organoids. Awarded on September 1, 2022 to the Broad Institute, Inc. with completion by August 31, 2025, the funding supports the Mental Health Research Grants program. The Broad Institute and collaborators at Harvard University will profile...
This $292,727 Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) supports a research project by The Broad Institute, Inc. to discover novel regulators of 3D genome organization. The project aims to leverage large-scale genomic datasets to predict and experimentally validate new trans-acting factors that regulate chromatin interactions and genome architecture. By applying deep neural network models to in silico genetic...
The National Science Foundation's Division of Molecular and Cellular Biosciences awarded a $412,249 CAREER grant to the University of California, Santa Barbara (UCSB) to study the spatial and epigenetic regulation of gene expression during early human development. The 5-year project aims to develop novel single-cell multiomics technologies that integrate transcriptome data with information on DNA methylation, chromatin accessibility, and histone modification patterns to understand how...

HOW GENOME ARCHITECTURE CONTROLS PROTOCADHERIN GENE CHOICE AT SINGLE-ALLELE RESOLUTION - PROJECT SUMMARY NEURAL SELF-AVOIDANCE IS A FUNDAMENTAL YET POORLY UNDERSTOOD PROCESS THAT IS ESSENTIAL FOR PROPER BRAIN WIRING. SELF-AVOIDANCE DESCRIBES THE TENDENCY OF NEURITES ORIGINATING FROM THE SAME CELL TO AVOID EACH OTHER WHILE INNERVATING TARGET BRAIN REGIONS AND FINDING SYNAPTIC TARGETS. THIS PROCESS IS MEDIATED BY THE CLUSTERED PROTOCADHERIN (PCDH) GENES, WHICH ARE DIFFERENTIALLY EXPRESSED BETWEEN NEURONS AND ACT AS CELL-SURFACE MOLECULAR BARCODES: NEURITES PRESENTING THE SAME COMBINATION OF PCDH ISOFORMS REPEL EACH OTHER, WHILE THOSE PRESENTING DIFFERENT COMBINATIONS CAN INTERACT. DESPITE THEIR CENTRAL ROLE IN BRAIN WIRING, THE REGULATION OF PCDH GENES REMAINS AN UNSOLVED PROBLEM IN NEUROSCIENCE. SPECIFICALLY, THE MECHANISM BY WHICH NEURONS CHOOSE SPECIFIC PCDH ISOFORMS TO EXPRESS DURING DEVELOPMENT, AND HOW THIS CHOICE IS MAINTAINED ACROSS THE LIFESPAN OF A NEURON, ARE UNCLEAR. RECENT WORK HAS DEMONSTRATED A ROLE FOR COHESIN-MEDIATED DNA LOOP EXTRUSION IN TUNING PCDH EXPRESSION ACROSS CELL TYPES, SUGGESTING THAT 3D GENOME ARCHITECTURE IS A CRITICAL DETERMINANT OF PCDH GENE CHOICE. THIS PROPOSAL AIMS TO TEST THIS MODEL IN VIVO BY USING OPTICAL RECONSTRUCTION OF CHROMATIN ARCHITECTURE (ORCA), A METHOD FOR IMAGING SINGLE-ALLELE GENOME STRUCTURE IN THOUSANDS OF SINGLE CELLS, TO STUDY PCDH LOCUS TOPOLOGY IN NEURONS OF THE OLFACTORY EPITHELIUM (OE) AND THEIR PRECURSORS. BY COMBINING ORCA WITH RNA LABELLING OF OE CELL TYPES AND PCDH ISOFORMS, THE FIRST AIM WILL ESTABLISH A DEVELOPMENTAL CLOCK OF PCDH GENE CHOICE THAT LINKS 3D GENOME FOLDING TO THE ONSET OF PCDH EXPRESSION DURING DEVELOPMENT. GENETIC MOUSE LINES WILL BE USED TO ABOLISH COHESIN ACTIVITY IN EACH CELL TYPE TO DETERMINE HOW COHESIN CONTROLS PCDH CHOICE ACROSS DEVELOPMENT. THE SECOND AIM WILL ADDRESS HOW CELLS ACHIEVE TRANSCRIPTIONAL STABILITY OF PCDH GENES ACROSS THEIR LIFETIMES BY CONSIDERING A ROLE FOR HETEROCHROMATIN IN THE CONTINUED SILENCING OF NON-CHOSEN PCDH GENES. THROUGH SINGLE-CELL SEQUENCING AND ORCA EXPERIMENTS, THE ABILITY OF HETEROCHROMATIN TO STABILIZE PCDH GENE EXPRESSION BY SEQUESTERING NON-CHOSEN PROMOTERS AWAY FROM PCDH ENHANCERS WILL BE TESTED. OVERALL, THESE STUDIES WILL HAVE IMPLICATIONS ACROSS MULTIPLE FIELDS, INCLUDING BRAIN WIRING, TRANSLATIONAL NEUROSCIENCE, AND GENE REGULATION. FIRST, THEY WILL REVEAL STRATEGIES BY WHICH NEURONS ESTABLISH PROPER MORPHOLOGIES, AN ESSENTIAL STEP IN CIRCUIT FORMATION ACROSS THE BRAIN, AS SEEN HERE THROUGH THE FORMATION OF OLFACTORY MAPS. SECOND, PCDH DYSREGULATION IS ASSOCIATED WITH MULTIPLE NEUROPSYCHIATRIC AND NEURODEGENERATIVE DISORDERS, INCLUDING SCHIZOPHRENIA AND AUTISM. THE PRINCIPLES OF PCDH GENE REGULATION SHOWN HERE WILL ADVANCE OUR UNDERSTANDING OF THESE DISORDER MECHANISMS AND IDENTIFY POTENTIAL AVENUES FOR THERAPEUTIC INTERVENTION. AND LASTLY, THE FUNCTIONS OF COHESIN IN GENE REGULATION HAVE BEEN DIFFICULT TO DETERMINE. THE PROTEIN COMPLEX HAS PRIMARILY BEEN STUDIED IN DIVIDING CELLS IN VITRO, WHERE IT ALSO PLAYS A VITAL ROLE IN SISTER CHROMATID COHESION DURING CELL DIVISION. THESE STUDIES WILL REVEAL NEW PHYSIOLOGICAL ACTIVITIES OF COHESIN IN SINGLE POST-MITOTIC CELLS IN VIVO AND THEREFORE SHED LIGHT ON LONG-STANDING DEBATES OVER THE ABILITY OF COHESIN TO ACTIVATE AND REPRESS GENES.

Posted 8/1/24, 12:00 AM